Article
The anti-obesity drug orlistat (Xenical) has been found to inhibit prostate cancer growth in a study of mice.
Phase 2 trial launches of autologous prostate cancer vaccine
Understanding Overactive Bladder (OAB): Pathophysiology, Diagnosis, and Management in Older Adults
Epigenomic cfDNA may accurately assess PSMA expression, Lu-PSMA response in mCRPC
Former MLB player Dave Winfield shares lessons from baseball, philanthropy
Behavioral intervention may improve psychological distress after testicular cancer
Capivasertib plus abiraterone extends rPFS in PTEN-deficient mHSPC